In summary, enhanced levels of both the membrane-bound and secretory forms of FcμR are evident in patients with CLL, possibly as the consequence of antigen-independent autonomous self-ligation of BCR on CLL cells. This evidence concerns the gene FCMR and B-cell chronic lymphocytic leukemia.